KNTE
Citadel Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-214,664
| Closed | -$571K | – | 7145 |
|
|
2024
Q1 | $571K | Sell |
214,664
-201,178
| -48% | -$535K | ﹤0.01% | 3750 |
|
|
2023
Q4 | $986K | Sell |
415,842
-644,001
| -61% | -$1.53M | ﹤0.01% | 3047 |
|
|
2023
Q3 | $1.48M | Sell |
1,059,843
-26,543
| -2% | -$37.2K | ﹤0.01% | 2667 |
|
|
2023
Q2 | $3.29M | Buy |
1,086,386
+12,837
| +1% | +$38.9K | ﹤0.01% | 2019 |
|
|
2023
Q1 | $6.71M | Sell |
1,073,549
-29,825
| -3% | -$186K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $6.73M | Buy |
1,103,374
+7,073
| +0.6% | +$43.1K | ﹤0.01% | 1560 |
|
|
2022
Q3 | $13.1M | Sell |
1,096,301
-31,088
| -3% | -$372K | ﹤0.01% | 1091 |
|
|
2022
Q2 | $14.2M | Sell |
1,127,389
-5,665
| -0.5% | -$71.4K | ﹤0.01% | 1044 |
|
|
2022
Q1 | $12.8M | Buy |
1,133,054
+11,350
| +1% | +$128K | ﹤0.01% | 1222 |
|
|
2021
Q4 | $19.9M | Sell |
1,121,704
-32,569
| -3% | -$577K | ﹤0.01% | 937 |
|
|
2021
Q3 | $26.6M | Sell |
1,154,273
-146,614
| -11% | -$3.38M | 0.01% | 736 |
|
|
2021
Q2 | $30.3M | Sell |
1,300,887
-14,763
| -1% | -$344K | 0.01% | 720 |
|
|
2021
Q1 | $41M | Buy |
1,315,650
+150
| +0% | +$4.67K | 0.01% | 564 |
|
|
2020
Q4 | $52.3M | Buy |
+1,315,500
| New | +$52.3M | 0.01% | 415 |
|